Millions Logo
home>Stocks>Solara Active Pharma Sciences
Solara Active Pharma Sciences
Solara Active Pharma SciencesHealthcare
689.65+135.95 (+24.55%)in 1 year
As on 13 Nov 2026 at 15:29
Start SIP
52 Week Low: 422.0052 Week High: 774.00

Solara Active Pharma Sciences Share Price Today

Solara Active Pharma Sciences opened at ₹676.20, in line with its previous close of ₹676.25. In the last trading session on 13 Nov 2026, the stock traded between ₹671.80 and ₹718.90, with an average traded price of ₹698.84. It showed an upward intraday trend.

Return calculator

Time Period

An investment of ₹10,000 made 5 years ago in Solara Active Pharma Sciences is now worth

₹ 6,668.00

Resulting in a loss of

₹ 3,332.00 (33.32%)

Invest now

Note: Past profits do not guarantee future returns.

Analyst Overview

No analyst rating data available.

Markets Today

Today's Change

+13.40 (+1.98%)

Day High

₹718.90

Day Low

₹671.80

Day Open

₹676.20

Prev Close

₹676.25

Volume

5,43,512

Value Traded

₹37.98 Cr

1W Return

7.21%

1M Return

4.07%

3M Return

36.40%

6M Return

35.60%

1Y Return

24.55%

Fundamentals

Market Cap (₹ Cr.)

3,315

PE Ratio

88.70

PB Ratio

2.28

Dividend Yield

0.44%

ROE

-0.59%

ROCE

6.07%

Book Value (₹)

295.98

Face Value (₹)

10.00

EPS (TTM)

5.92

Industry PE

-

Beta

-

Debt to Equity

-

Investment Returns

1 Week

7.21%

6 Weeks

-

1 Month

4.07%

3 Months

36.40%

9 Months

43.66%

Financials

Yearly
Consolidated
All values in ₹ crores
16.46

Mar 21
12.88

Mar 22
14.66

Mar 23
12.94

Mar 24
12.92

Mar 25
13.75

Mar 26

Share Holding Pattern

Promoter41.93%
FII10.71%
DII3.89%
Retails & Others27.62%

Updates

23Oct

Solara Active Pharma Q2FY27 Results: EBITDA doubles 118% YoY to ₹76.9 crore

Net profit turned positive at ₹28.46 crore against a loss of ₹10.10 crore in Q2FY26. Revenue rose 33.1% YoY to ₹417.34 crore, driven by 37% growth in base business. Ibuprofen segment EBITDA loss narrowed to ₹0.2 crore; strategic review decision expected in 12 weeks. Net debt reduced to ₹500 crore, improving net debt/EBITDA ratio to 1.8x from 3.2x. Exceptional item loss of ₹4.50 crore recorded due to sale of Vizag plant equipment.

22 days ago
13Oct

Solara Active Pharma to host analyst call on Oct 16 for Q2FY27 results

Solara Active Pharma Sciences scheduled an analyst call for October 16, 2026. The meeting will cover unaudited financial results for Q2FY27 and H1FY27. Conference call is set for 4:00 pm IST with participation from MD & CEO and CFO. Dial-in details provided for investors and analysts joining the group meet.

1mo ago
9Oct

Solara Pharma approves forfeiture notice for unpaid rights shares

Solara Active Pharma Sciences approved a final reminder-cum-forfeiture notice on October 9, 2026. The notice applies to holders of partly paid-up rights shares with unpaid call money. Outstanding amounts include both first and second/final call money. The company will intimate stock exchanges upon dispatch of the final notice.

1mo ago
22Sep

Solara Active Pharma declares AGM voting results; all resolutions pass

All five resolutions at Solara Active Pharma's Ninth AGM passed with requisite majority. ₹480 crore related-party transaction with Strides Pharma approved by 99.87% of valid votes. Promoters abstained from voting on the related-party deal due to interest in the agenda. Voting results disclosed under Regulation 44 of SEBI Listing Regulations.

1mo ago
28Aug

Solara Active Pharma gets ₹161.92 crore tax demand dropped for AY 2019-20

Solara Active Pharma Sciences received a rectification order dropping a ₹161.92 crore tax demand. The dispute related to Assessment Year 2019-20 and was resolved by the Thane income tax authority. The company confirmed there is no financial or operational impact from this development. No penalties or sanctions were imposed as part of the resolution.

2mo ago
25Aug

Solara Active Pharma files FY26 sustainability report with 81% renewable energy mix

Renewable energy constituted 81% of total energy consumption in FY26. Permanent employee turnover rate fell to 13% from 30% in FY25. Sales to related parties rose to 25% of total sales from 17.6%. Scope 1 and 2 GHG emission intensity declined to 0.0000027 tCO₂e/₹. Total water withdrawal increased to 3,81,529 KL from 3,17,477 KL.

2mo ago

Similar Stocks

StockLTPChange %Market Cap (Cr.)PE1Y Return
₹1,880.00-0.27%₹4,51,074.9741.20+8.54%
₹11,442.00-0.37%₹3,03,749.1590.40+75.49%
₹4,670.00-1.21%₹1,77,631.7985.50+22.10%
₹2,424.00+1.00%₹1,30,971.6897.10+145.03%
₹1,189.90-1.33%₹1,18,692.9828.00+25.07%
₹1,380.00-0.48%₹1,15,185.8842.00+12.23%
₹1,391.80-1.17%₹1,12,437.7439.90-8.39%
₹2,640.00+0.05%₹1,09,043.9048.10+16.30%
₹1,823.20+0.89%₹1,04,902.9026.00+54.04%
₹1,980.30-1.72%₹90,557.1317.60-2.64%
₹2,640.00-0.74%₹74,507.3151.60+42.87%
₹5,114.00-3.55%₹61,145.5430.50-11.33%